Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL CellsYamit Shorer Arbel, Yair Herishanu|Frontiers in Oncology|2021Cited by 15